ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,202Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 680

$849K Total Retail Price of All Prescriptions

Rank: 121 out of 680

632 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 15,806 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 709 633 1 3
AMLODIPINE BESYLATE 632 568 2 1
HYDROCHLOROTHIAZIDE 521 495 3 9
FUROSEMIDE 482 439 4 6
OMEPRAZOLE 476 430 5 7
LEVOTHYROXINE SODIUM 459 416 6 2
METFORMIN HCL 451 423 7 8
LISINOPRIL 420 409 8 5
TRAMADOL HCL 400 384 9 18
METOPROLOL SUCCINATE 353 328 10 13
MELOXICAM 343 306 11 24
CITALOPRAM HBR 322 307 12 22
LANTUS 289 252 13 49
ZOLPIDEM TARTRATE 275 259 14 17
DONEPEZIL HCL 268 268 15 27
WARFARIN SODIUM 264 249 16 20
ATORVASTATIN CALCIUM 227 222 17 11
ATENOLOL 208 195 18 19
CARVEDILOL 198 189 19 23
AZITHROMYCIN 192 164 20 42
CLOPIDOGREL 180 171 21 26
POTASSIUM CHLORIDE 179 168 22 14
AMLODIPINE BESYLATE-BENAZEPRIL 173 160 23 43
METOPROLOL TARTRATE 170 166 24 12
ALLOPURINOL 168 146 25 33
GLIMEPIRIDE 163 157 26 29
DIOVAN 159 158 27 31
SYNTHROID 159 154 27 38
TAMSULOSIN HCL 158 139 29 34
SERTRALINE HCL 154 154 30 28
LOVASTATIN 152 137 31 44
CRESTOR 148 147 32 25
GABAPENTIN 143 139 33 15
NAMENDA 138 138 34 35
ALENDRONATE SODIUM 134 134 35 32
QUINAPRIL HCL 129 129 36 104
LOSARTAN POTASSIUM 127 113 37 21
AMITRIPTYLINE HCL 118 104 R 38 47
PLAVIX 118 112 38 39
POLYETHYLENE GLYCOL 3350 105 100 40 62
ADVAIR DISKUS 102 92 41 53
BISOPROLOL-HYDROCHLOROTHIAZIDE 97 89 42 156
ACTOS 96 88 43 114
NEXIUM 96 84 43 16
PRAVASTATIN SODIUM 95 94 45 10
MECLIZINE HCL 93 85 46 103
VERAPAMIL ER 86 86 47 100
GLYBURIDE 86 86 R 47 85
JANUVIA 83 69 49 60
INSULIN SYRINGE 81 72 50 86
LIPITOR 79 78 51 68
CLONIDINE HCL 79 77 51 36
ESCITALOPRAM OXALATE 78 77 53 45
METFORMIN HCL ER 77 67 54 54
METHYLPREDNISOLONE 76 68 55 93
BENAZEPRIL HCL 74 68 56 40
QUETIAPINE FUMARATE 73 73 57 64
DILTIAZEM 24HR ER 71 70 58 132
HYDROCODONE-ACETAMINOPHEN 71 64 S3 58 4
LOSARTAN-HYDROCHLOROTHIAZIDE 71 59 58 51
ENALAPRIL MALEATE 70 70 61 65
SINGULAIR 68 65 62 91
SPIRONOLACTONE 67 66 63 82
DIGOXIN 65 50 64 58
ZETIA 64 54 65 87
RAMIPRIL 64 49 65 69
PREDNISONE 63 58 67 50
AMIODARONE HCL 63 63 67 158
PANTOPRAZOLE SODIUM 62 29 69 30
CYCLOBENZAPRINE HCL 61 46 R 70 81
CIPROFLOXACIN HCL 60 57 71 57
GLIPIZIDE 58 44 72 63
LYRICA 58 56 72 77
DIOVAN HCT 56 47 74 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 45 75 37
DETROL LA 55 55 75 169
FLUTICASONE PROPIONATE 55 49 75 41
NITROFURANTOIN 52 51 78 269
TRIAMTERENE-HCTZ 52 51 78 52
FOSINOPRIL SODIUM 51 51 80 203
PHENYTOIN SODIUM EXTENDED 51 40 80 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.